06 Dec 2021 | 03:45 PM GMT

Masterclass: How to get your DTx product reimbursed in the US?

About this Meeting

Are you a DTx company seeking reimbursement in the US? Keep reading, this masterclass is for you. Even though showing evidence and gaining regulatory approval are important steps in the DTx commercialization journey, getting paid is crucial in order to thrive. While there are alternate commercialization models that may fit different firms at different stages with different objectives, like D2C or partnerships with pharma, getting reimbursed by public and private payers will be critical to reach the reimbursed Rx levels needed for higher revenues from DTx products. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through (***important note below): 

  • What are the drivers and requirements for payers to reimburse DTx products/services?  
  • Payers’ engagement best practices to meet their expectations. 
  • Pharmacy Benefit Managers (PBMs) Contracting Basics - Role of Pharmacy Benefit Managers (PBMs) as an entry point for DTx reimbursement - is being included in their formularies enough?

 ***IMPORTANT - this is the second part of a masterclass we ran in November, hence the main focus will be on the topics we didn’t have time to cover in the previous session.